Trending

lupus

Could phase 3 trial win save AZ’s troubled Lupus drug?

Could phase 3 trial win save AZ’s troubled Lupus drug?

AstraZeneca has been on a hot streak of trial successes recently, with the latest win being in a

X

Could phase 3 trial win save AZ’s troubled Lupus drug?

https://pharmaphorum.com/news/could-phase-3-trial-win-save-azs-troubled-lupus-drug/

Roche’s Gazyva shows promise in Lupus nephritis trial

Roche’s Gazyva shows promise in Lupus nephritis trial

Roche’s Gazyva is already approved in leukaemia and lymphoma – but could it work in the autoimmune kidney

X

Roche’s Gazyva shows promise in Lupus nephritis trial

https://pharmaphorum.com/news/roches-gazyva-shows-promise-in-lupus-nephritis-trial/

FDA approves first treatment for children with lupus

FDA approves first treatment for children with lupus

The US FDA has approved GSK’s Benlysta (belimumab) intravenous infusion for the treatment of children with lupus. While

X

FDA approves first treatment for children with lupus

https://pharmaphorum.com/news/fda-approves-first-treatment-children-lupus/

AZ’s lupus drug fails in late-stage trial

AZ’s lupus drug fails in late-stage trial

AZ will launch full review after further phase 3 results later this year

X

AZ’s lupus drug fails in late-stage trial

https://pharmaphorum.com/news/astrazeneca-anifrolumab-fails-trial/

Gilead to collaborate with Google’s Verily in inflammatory diseases

Gilead to collaborate with Google’s Verily in inflammatory diseases

Gilead has signed a three-year deal with Google’s life science division Verily to work on identifying the immunological

X

Gilead to collaborate with Google’s Verily in inflammatory diseases

https://pharmaphorum.com/news/gilead-google-verily-inflammatory-disease-research/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com